West Virginia University Logo

Behavioral and Biomedical Sciences Symposium

Translational Science: From Mouse to Mankind

Friday, May 4, 2018

8:30 a.m. - 1:00 p.m.

Room G119, Health Sciences North


Schedule of Events

8:30 - 9:00 a.m. - Continental Breakfast

9:00 - 10:00 a.m. - T32 Trainee Presentations

10:30 - 10:45 a.m. - Break

10:45 - 11:15 a.m. - Dr. Mark Olfert - Director, Clinical and Translational Science PhD program

11:15 - 11:45 a.m. - Dr. Sally Hodder - Associate Vice President for Clinical & Translational Science/Director, WVCTSI

11:45 - noon - Break

Noon - 1:00 p.m. - Keynote Speaker: Dr. Howard Gutstein

Howard Gutstein, MD, is an anesthesiology at the University of Pittsburgh with joint appointments in the departments of Pediatrics, Neurobiology, Cell Biology, and Pharmacology and Chemical Biology. During a year-long appointment in 1997 at the Ontario Cancer Institute (University of Toronto, Canada), Dr. Gutstein worked with Dr. David Siderovski on the original cloning of Regulator of G protein Signaling-12 (RGS12). Dr. Gutstein’s current research focuses on the molecular mechanisms underlying development of opioid tolerance and dependence. For more information, please visit: https://www.anesthesiology.pitt.edu/people/howard-b-gutstein-md.